Changes in alkaline phosphatase levels in patients with prostate cancer receiving degarelix or leuprolide: results from a 12-month, comparative, phase III study. (Q34613787)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Changes in alkaline phosphatase levels in patients with prostate cancer receiving degarelix or leuprolide: results from a 12-month, comparative, phase III study. |
scientific article |
Statements
Changes in alkaline phosphatase levels in patients with prostate cancer receiving degarelix or leuprolide: results from a 12-month, comparative, phase III study (English)
Laurent Boccon-Gibod
Fritz H Schröder
Kurt Miller
Neal D Shore
E David Crawford
Judd Moul
Tine Kold Olesen
Bo-Eric Persson
13 November 2009